Diabetes Mellitus, Type 2 Clinical Trials
60 studies are recruiting for diabetes mellitus, type 2 in the United States right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.
Search these by distance from you
By city
Studies, page 2
-
A Trial Evaluating AMG 127 in Healthy Participants and Participants With Type 2 Diabetes Mellitus
The main objective of this trial is to assess the safety and tolerability of AMG 127 as single dose and multiple doses in healthy participants and participants with type 2 diabetes mellitus (T2DM).
- Stage
- Phase 1
- Ages
- 18 to 75
- Site
- Orange County Research Center, Lake Forest, California
- Locations
- 2 in total
- Run by
- Amgen
-
Re-Engineered Discharge for Diabetes Care Transitions
The goal of this project is to test a novel bedside SDOH screening intervention coupled with post-discharge navigation for hospitalized patients with a diabetes diagnosis to reduce unmet social needs, compared to usual care.
- Stage
- Not phased
- Ages
- 18 and older
- Site
- UMASS Memorial Healthcare System, Worcester, Massachusetts
- Run by
- University of Massachusetts, Worcester
-
Effect of Endoscopic Sleeve Gastroplasty in Patients With Obesity and MASH: A Randomized Controlled Trial
Metabolic dysfunction-associated steatotic liver disease (MASLD) is the most common chronic liver disease globally. While weight loss through lifestyle modification is the standard treatment, most patients regain weight limiting ultimate improvement in liver disease. On the other end of the spectru…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Brigham and Women's Hospital, Boston, Massachusetts
- Locations
- 2 in total
- Run by
- Pichamol Jirapinyo, MD, MPH
-
OASIS: Peer Support for T2DM in Appalachia (Peer Coaches)
The goal of this clinical trial is to compare the effects of peer coaching models in older adults with unmanaged type two diabetes. The main questions it aims to answer are: * Are peer coaching models effective at promoting Type 2 Diabetes Mellitus self-management? * If effective, which facets of t…
- Stage
- Not phased
- Ages
- 55 and older
- Site
- Barren River Area Development District, Bowling Green, Kentucky
- Locations
- 2 in total
- Run by
- The University of Texas Medical Branch, Galveston
-
OASIS: Peer Support for T2DM in Appalachia (Peer Participant)
The goal of this clinical trial is to compare the effects of peer coaching models in older adults with unmanaged type two diabetes. The main questions it aims to answer are: * Are peer coaching models effective at promoting Type 2 Diabetes Mellitus self-management? * If effective, which facets of t…
- Stage
- Not phased
- Ages
- 55 and older
- Site
- Barren River Area Development District, Bowling Green, Kentucky
- Locations
- 2 in total
- Run by
- The University of Texas Medical Branch, Galveston
-
Primary Care Pragmatic, Real World Experience for Automated Insulin Delivery
The goal of this randomized controlled trial is to compare the efficacy and safety of the iLet Bionic Pancreas (BP) System in adults with insulin-treated diabetes (type 1 diabetes or type 2 diabetes) compared to standard of care when ordered by primary care providers. The main question it aims to a…
- Stage
- Not phased
- Ages
- 18 to 89
- Site
- University of Colorado Anschutz Medical Campus, Aurora, Colorado
- Locations
- 2 in total
- Run by
- University of Colorado, Denver
-
Glucose and Activity Tracking for Sedentary Behavior Interventions in Older People With Type 2 Diabetes (TRACK T2D)
The overarching goal of this explanatory mixed methods study is to evaluate how older people living with type 2 diabetes (T2D) integrate continuous glucose monitor (CGM) and activity data in diabetes self-management, and how this technology supports reduced sedentary behavior (SB) and improved gluc…
- Stage
- Not phased
- Ages
- 55 and older
- Site
- University of Minnesota, Minneapolis, Minnesota
- Run by
- University of Minnesota
-
Milk for Diabetes Prevention
Individuals with lactase non-persistence (LNP; determined by a functional variant in the LCT gene [rs4988235, GG genotype]) are susceptible to lactose intolerance in adulthood due to deficiency of lactase, the enzyme which digests milk lactose sugars. However, many LNP individuals still drink ≥1 cu…
- Stage
- Not phased
- Ages
- 18 to 70
- Site
- HCHS/SOL Bronx Field Center, The Bronx, New York
- Run by
- Albert Einstein College of Medicine
-
Mixed Methods Study of Health-Related Social Needs in African American Adults With Chronic Kidney Disease and Type 2 Diabetes Mellitus
The overarching goal of this study is to understand facilitators and barriers to self-care, develop and refine a culturally tailored intervention to improve clinical outcomes, quality of life (QOL), and self-care behaviors in African American adults with diabetic kidney disease (DKD) experiencing h…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Medical College of Wisconsin, Milwaukee, Wisconsin
- Run by
- Medical College of Wisconsin
-
Implementing Scalable, PAtient-centered, Team-based, Technology-enabled Care for Adults With Type 2 Diabetes (iPATH)
Sixteen institutions will be selected from a HRSA uniform data system and have data collected for up to 3 years. Eight institutions will begin the iPATH practice transformation during year one, the other eight institutions will begin iPATH in year two. FQHC administrators, clinicians and staff will…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Board of Trustees of the Leland Stanford Junior University, Stanford, California
- Locations
- 4 in total
- Run by
- Stanford University
-
Gemini Study: A Prospective, Multicenter Evaluation of Performance and Safety of the Eversense Gemini System With Flash Glucose Measurement Feature
A prospective, multicenter evaluation of performance and safety of the Eversense Gemini System with flash glucose measurement feature. The purpose of this clinical investigation is to evaluate the accuracy of the Gemini System with new technological flash glucose monitoring (FGM) feature enhancemen…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Headlands Research - AMCR Institute, Escondido, California
- Run by
- Senseonics, Inc.
-
ROME GS System Study
The purpose of this clinical investigation is to demonstrate that the proposed physical changes to the ROME GS Sensor do not have any adverse impact on safety and performance when compared to the Eversense 365 Sensor.
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Headlands Research - AMCR Institute, Escondido, California
- Locations
- 4 in total
- Run by
- Senseonics, Inc.
-
Normal-weight Diabetes: Adipocyte-directed Therapy With Pioglitazone or Tirzepatide
This study is to investigate how adipocyte (fat cell) function and fat distribution differ between individuals with normal-weight type 2 diabetes (NWD), those with overweight type 2 diabetes (OWD), and normal-weight controls without diabetes (NWC). The study will assess whether adipocyte-directed t…
- Stage
- Phase 4
- Ages
- 30 to 70
- Site
- Stanford University, Palo Alto, California
- Locations
- 2 in total
- Run by
- Stanford University
-
Boosting Emotional Well-being and Happiness in Outpatients Living With Diabetes
The focus of this study is to test the efficacy of an 8-week, remotely delivered, positive-psychology-motivational interviewing (PP-MI) intervention, with additional twice weekly text messages for a total of 16 weeks (with interactive, algorithm-driven, goal-focused text messages in the final 8 wee…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Massachusetts General Hospital, Boston, Massachusetts
- Run by
- Massachusetts General Hospital
-
Project Dulce for Arab Americans With Type 2 Diabetes
Arab Americans (AA) face many challenges in diabetes self-management due to the limited educational resources and support available for them. The cultural and linguistic barriers between patients and health care providers lead to poor diabetes management and outcomes. This study (Project Dulce Arab…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Metro Caring, Denver, Colorado
- Locations
- 2 in total
- Run by
- Scripps Whittier Diabetes Institute
-
Transformative Research in Diabetic Nephropathy 2.0
The goal of this observational study is to learn more about kidney health in adults with diabetic kidney disease and other groups. Researchers will study kidney tissue and other samples. They want to learn how sodium-glucose cotransporter-2 (SGLT2) inhibitors, a type of diabetes medicine, may affec…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Penn Presbyterian Medical Center, Philadelphia, Pennsylvania
- Run by
- University of Pennsylvania
-
Pilot-Testing Real-Time Engagement for Learning to Effectively Control Type 2 Diabetes
The goal of this study is to pilot test features of a new smartphone app and to gather feedback related to wearing a continuous glucose monitor (CGM) and a Fitbit device, as well as to obtain input on health behavior-focused messages delivered through the app. The study will enroll English-speaking…
- Stage
- Not phased
- Ages
- 16 to 24
- Site
- Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania
- Run by
- University of Pittsburgh
-
Blood Markers of Early Pancreas Cancer
Identifying biomarkers of early pancreatic ductal adenocarcinoma (PDAC) could facilitate screening for individuals at higher than average risk and expedite the diagnosis in individuals with symptoms and substantially improve an individual's chance of surviving the disease. The investigators propose…
- Stage
- Not phased
- Ages
- 19 and older
- Site
- Unversity of Nebraska Medical Center, Omaha, Nebraska
- Run by
- University of Nebraska
-
Use of CGM in Kidney Transplant Recipients
The investigators want to study the impact CGM (continuous glucose monitoring) has on patients glycemic control as determined by time in range (TIR 70-180 mg/dL) in the Diabetic Kidney Transplant population.
- Stage
- Not phased
- Ages
- 18 and older
- Site
- UC Davis Health, Sacramento, California
- Run by
- University of California, Davis
-
Drug Interaction Potential of Pro-Inflammatory Conditions
Pro-inflammatory cytokines, which are elevated in pro-inflammatory disease states (e.g., type II diabetes mellitus [T2DM], irritable bowel diseases [IBD], and end stage renal disease [ESRD]) have been shown to inhibit hepatic drug-metabolizing enzymes, including members of the cytochrome P450 (CYP)…
- Stage
- Not phased
- Ages
- 12 to 99
- Site
- Indiana University Hospital, Indianapolis, Indiana
- Run by
- Indiana University
-
Improving Diabetes Care With Strategies For Addressing Health-Related Social Needs and Community Partnerships
The goal of this study is to develop, implement, and evaluate a patient-centered triage and referral model designed to improve health outcomes for individuals with uncontrolled type 2 diabetes mellitus (T2DM) and unmet health-related social needs. The intervention builds on the existing THRIVE infr…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Boston Medical Center, Boston, Massachusetts
- Run by
- Boston Medical Center
-
Family Model DSME in FBOs in the RMI
Health disparities in the Republic of the Marshall Islands are striking, with extremely high rates of type 2 diabetes. Documented prevalence of type 2 diabetes in the Marshall Islands ranges from 20%-50%.This is significantly higher than the global (8.5%) and United States (11%) prevalence. Diabete…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- UAMS Institute for Community Health Innovation, Springdale, Arkansas
- Run by
- University of Arkansas
-
Post Prandial Individual Responses to Different Foods
This study aims to understand why people respond differently to the same foods, especially when it comes to changes in blood sugar after eating. A continuous glucose monitors (CGMs) will be used to observe how individuals respond to specific meals and drinks (e.g., Oral Glucose Tolerance Test, OGTT…
- Stage
- Not phased
- Ages
- 18 to 80
- Site
- Stanford University, Stanford, California
- Run by
- Stanford University
-
SCS for Patient With Painful Diabetic Neuropathy and Peripheral Arterial Disease
Peripheral arterial disease (PAD) affects over 230 million adults worldwide and is a highly morbid, costly, and disabling condition. Ischemic leg pain drives disability in PAD patients and results from oxygen supply-demand mismatch, autonomic dysfunction, and muscle breakdown. This leg pain, which …
- Stage
- Not phased
- Ages
- 19 to 89
- Site
- University of Nebraska Medical Center, Omaha, Nebraska
- Run by
- University of Nebraska
-
Linking Education, Produce Provision, and Community Referrals to Improve Diabetes Care (LINK)
This is a pragmatic randomized controlled trial (pRCT) that aims to test the effect of produce provision, diabetes education, and community referrals on hemoglobin A1c levels in individuals with type 2 diabetes experiencing food insecurity.
- Stage
- Not phased
- Ages
- 18 and older
- Site
- The Ohio State University Wexner Medical Center, Columbus, Ohio
- Run by
- Ohio State University
How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.
What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.
Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.